Table 1.
Results of three recent European multicentre trials evaluating CT colonography screening
Study acronym (first author and year) | Number of invitees |
Population age range (years) |
Participation rate (%) |
Diagnostic yield; advanced neoplasms per 100 participants | Diagnostic yield; advanced neoplasms per 100 invitees | |||
CTC | Comparator(s) | CTC | Comparator | CTC | Comparator | |||
COCOS (Stoop et al 2012)46 (Tutein et al 2015)51 |
8,844 82b |
Never screened 50–75 |
34 | OC - 22 | 6.1a 8.6b |
OC - 8.7 | 2.1 2.9b |
OC - 1.9 |
SAVE (Sali et al 2016)45 |
16,087 | Never screened 54–65 |
28c 25d |
FIT - 50d OC - 15 |
5.5c 4.9d |
FIT - 1.7e OC - 7.2 |
1.5c 1.2d |
FIT - 0.9e OC - 1.1 |
PROTEUS1 & 2 (Regge et al 2017)44 |
42,929 | Never screened 58–60 |
30f | FS - 27f | 5.1a | FS - 4.7a | – | – |
CTC, computed tomographic colonography; OC, optical colonoscopy.
Using a threshold of 10 mm or greater to precipitate referral for colonoscopy. Patients with 6–9 mm polyps were initially enrolled in CTC follow-up.
After inclusion of the follow-up cohort of patients with 6–9 mm polyps detected at initial CTC.
Reduced preparation CTC group.
Full-preparation CTC group.
Data from PROTEUS1.